Literature DB >> 33725116

Response-letter to the editor: colchicine and risk of non-cardiovascular death in patients with coronary artery disease: a pooled analysis underlying possible safety concerns.

Mattia Galli1,2, Giuseppe Princi1, Filippo Crea1, Domenico D'Amario1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 33725116     DOI： 10.1093/ehjcvp/pvab024

Source DB:  PubMed          Journal:  Eur Heart J Cardiovasc Pharmacother


× No keyword cloud information.
  2 in total

1.  Modulating inflammation to reduce atherosclerotic cardiovascular events: should colchicine be part of the therapeutic regimen?

Authors:  Ishwarlal Jialal; Naval Vikram
Journal:  Ther Adv Cardiovasc Dis       Date:  2021 Jan-Dec

Review 2.  The Role of Colchicine in Atherosclerosis: From Bench to Bedside.

Authors:  Leticia González; Juan Francisco Bulnes; María Paz Orellana; Paula Muñoz Venturelli; Gonzalo Martínez Rodriguez
Journal:  Pharmaceutics       Date:  2022-07-01       Impact factor: 6.525
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.